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Clq, Cls and CT Inh synthesized and secreted by human monocytes were characterized by SDS-PAGE. 
Clq is formed of three chains A (A4, -35000), B (Mr -33000) and C (Mr -25000) which are associated 
in two subunits A-B and C-C. It appears identical to Clq purified from plasma. Cls is secreted as a non- 
activated, monocatenar protein of M, -87000 identical to proenzymic Cls from plasma. Secreted Ci Inh 
(M, N 100000) has a slightly higher M, than purified plasmatic Ci Inh. Monensin treatment of the cells 
favours the intracytoplasmic a cumulation f products at various glycosylation stages. 
Human Cl Human Ci Inh 
1. INTRODUCTION 
Cl, the first component of complement, cir- 
culates in plasma as a calcium-dependent associa- 
tion of two loosely bound subcomplexes, Clq and 
Clr2-Cls2. Activation of Cl, which triggers the 
classical pathway of complement, reflects a modu- 
lation of the intrinsic autocatalytic properties of its 
dimeric Clr subcomponent [l]. Ci Inh controls Cl 
activation [2] and Cl activity [3]. 
We have shown that cultured human monocytes 
are able to synthesize the whole Cl subcomponents 
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Abbreviations: FCS, heat-inactivated foetal-calf serum; 
PBS, phosphate-buffered saline; NP 40, Nonidet P-40; 
DFP, di-isopropyl phosphofluoridate; IgG, immuno- 
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light chains; SDS-PAGE, SDS-polyacrylamide gel elec- 
trophoresis 
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ponents is that recommended by World Health Organi- 
zation (1968). Activation of a component is indicated by 
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Macrophage Biosynthesis 
of Cl and Ci Inh, when these cells are activated by 
conditioned media from stimulated lymphocytes 
[4]. The purpose of this paper is to characterize 
Clq, Cls and Ci Inh synthesized and secreted by 
these cells, the circulating proteins being taken as 
a reference. 
2. MATERIALS AND METHODS 
2.1. Culture and biosynthetic labeling 
Monocytes were prepared and cultivated as 
described in [4]. After 8 days the medium was sup- 
plemented with 10% (v/v) conditioned medium 
prepared from concanavalin A stimulated lym- 
phocytes according to [4]. Biosynthetic labeling 
was conducted after 12-15 days of culture; the cells 
were washed with RPM1 lacking leucine or proline 
(Selectamine, Flobio) supplemented with 20% FCS 
and 10% conditioned medium, then incubated for 
24 h in the same medium containing 12.5 &i/ml 
t4C-labeled L-leucine (300 mCi/mmol, Amersham) 
or 12.5 &i/ml i4C-labeled L-proline (250 mCi/ 
mmol, Amersham). Following incubation the 
medium was removed, centrifuged for 5 min at 
10000 x g, extensively dialysed against PBS and 
stored at -20°C. The cells were washed with PBS 
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and lysed by 0.5% NP40, 0.5% sodium deox- 
ycholate, 100 mM KCl, 10 mM EDTA, 5 mM 
DFP, 50 mM Tris-HCl, pH 7.4. The lysates were 
freeze-thawed twice, centrifuged for 30 min at 
10000 xg and stored at -20°C. 
2.2. Immunoprecipitation 
Specific IgG to Clq, F(ab’)2 fragment of 
specific IgG to Cis or immunoglobulin from an- 
tiserum to CT Inh were coupled to activated cova- 
spheres Mx (Covalent Technology Corporation) as 
described by the manufacturer. 1 ml medium or 
cell lysate was made 5 mM in EDTA and 5 mM in 
DFP, then rotated for 18 h at room temperature 
with 20 or 50 ~1 of the appropriate covaspheres. 
The covaspheres were collected by centrifugation 
and washed 5 times with 1 ml 0.15 M NaCl, 0.5% 
NP40, 0.5 mM EDTA, 0.02% NaN3 in 0.05 M 
Tris-HCl, pH 7.4. The covaspheres were then ex- 
tracted by 0.1 ml 3% SDS for 30 min at 37°C. The 
extracts were mixed with equal volumes of 8 M 
urea, 0.2 M Tris-HCl, pH 8.0, then reduced 
samples were prepared by incubation for 1 h at 
37°C with 50 mM DTT followed by alkylation for 
20 min at 37°C with 133 mM iodoacetamide and 
non-reduced samples by incubation for 1 h at 37°C 
with 20 mM iodoacetamide. 
2.3. SDS-PAGE 
SDS-PAGE was conducted according to Laemmli 
[5] using 10 or 7.5% acrylamide gels. i4C-labeled 
M, markers (Amersham) were included in each 
slab. After electrophoresis the gels were fixed by 
soaking in 25% trichloroacetic acid overnight, 
washed for 1 h with water, impregnated for 30 min 
with 1.5 M sodium salicylate, dried and exposed to 
Kodak X-omat AR film at -70°C. 
3. RESULTS 
3.1. Biosynthesis of Clq 
The particular amino acid composition of the 
collagenous tail of Clq was taken into account to 
enhance Clq specific labeling by choosing [14C]- 
proline as biosynthetic label. Monocytes were 
cultivated in the presence of [r4C]proline then the 
culture supernatants and the cell lysate were im- 
munoprecipitated with covasphere-bound anti-Clq 
IgG. The immunoprecipitates were solubilized in 
3% SDS and run on SDS-PAGE in reducing and 
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Fig. 1. Immunoprecipitation f Clq synthesized by 
monocytes. Autoradiograph following SDS-PAGE of 
Clq immunoprecipitated from li4C]proIine labeled 
culture medium (lane 1, non-reduced sample; lane 2, 
reduced sample) and cell lysate (lane 3, non-reduced 
sample; lane 4, reduced sample). 
non-reducing conditions. 
When the immunoprecipitation was made on the 
culture supernatant (fig. 1, lanes 1 and 2) the re- 
duced sample shows the 3 bands characteristic of 
serum Clq, A, B and C at Mr - 35 000,33 000 and 
25 000; the non-reduced sample shows the A-B and 
C-C dimers of Clq at M, - 57 000 and 46 000. An 
extra band of Mr - 52 000 in the non-reduced sam- 
ple and iw; - 40~ in the reduced sample was 
always found; this band could be compared to the 
reduced bands of M, - 47 000 and 42 000 which 
have been shown to be synthesized by fibroblast 
cultures [6]. The reduced sample also shows a band 
ofM, - 200 000 which does not penetrate into the 
gel when non-reduced; the identity of this band is 
not certain but it could correspond to secreted 
fibronectin which is known to bind to Clq (review 
I71). 
When the immunoprecipitation was made on the 
cell lysate (fig.1, lanes 3 and 4) both reduced and 
non-reduced samples showed the same bands as 
secreted Clq. However A chain seemed to be 
predominant over B and C chains; this could be 
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due to a combination of a partial dissociation of 
intracellular Clq in its two dimers A-B and C-C 
and a preferential affinity of polyclonal anti-CIq 
IgG for epitopes of A chain. There was no evi- 
dence of proClq. 
3.2. Biosynthesis of Cls 
Cls biosynthesis was studied with [i4C]leucine as 
label. Covasphere-bound anti-C% F(ab’)2 was us- 
ed as immunoprecipitant to avoid eventual Fc bin- 
ding of synthesized Clq. 
Immunoprecipitates from culture supernatant 
(fig.2, lanes 1 and 2) showed a single band of Mr 
- 87000 in reduced form. Secreted Cls thus ap- 
peared as a monocatenar protein; there was no 
evidence of A and B chains, indicating that se- 
creted Cls was entirely in its proenzymic form. 
When the immunoprecipitation was made on 
cellular lysates, Cls was hardly detectable over the 
background; this is probably related to the low in- 
tracytoplasmic accumulation of this protein that 
-3 
Mt%lO 
we had noticed [4]. Monensin was used to enhance 
intracytoplasmic protein accumulation, Fig.2 
(lanes 3 and 4) shows the electrophoretic pattern of 
immunoprecipitates from lysates of cells labeled in 
the presence of 2 PM monensin. At least one band 
identical to secreted Cls appeared both in reduced 
and non-reduced samples. 
3.3. Biosynthesis of CrInh 
Fig.3, lane 1 shows the electrophoretic pattern 
of Ci Inh immunoprecipitated from culture super- 
natant, labeled with [i4C]leucine. Secreted C] Inh 
appears as a monocatenar protein of M, - 100000, 
slightly higher than its purified plasmatic counter- 
part of ikf, - 9500tl (fig.3, lane 2). 
Monensin was used to promote intracytoplasmic 
accumulation of Ci Inh which otherwise was hard- 
ly detectable. Immunoprecipitates of lysates from 
monensin-treated cells show a diffuse band be- 
tween I%& - 80OOOandM, - 90000 (fig.3, lane 3), 
which could be accounted for by different degrees 
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Fig.2 Immunoprecipitation of Cls synthesized by 
monocytes. Cls was immunoprecipitated from [14C]leu- 
tine labeled culture medium and from lysates of cells 
labeled [‘4C]leucine in the presence of 2 /tM monensin. 
The immunoprecipitates were analysed by SDS-PAGE 
and fluorography. Lanes 1 and 2, non-reduced and 
reduced secreted Cls; lanes 3 and 4, non-reduced and 
reduced intracytoplasmic Cls. 
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Fig.3. Immunoprecipitation of CI Inh synthesized by 
monocytes. C] Inh was immunoprecipitated from 
[‘%J]leucine labeled culture medium and from medium 
and lysates of cells labeled by [‘4C]leucine in the 
presence of 2 PM monensin. The immunoprecipitates 
were anslysed by SDS-PAGE in reducing conditions and 
fluorography. Lane 1, ‘251-labeled purified plasmatic Cl 
Inh; lane 2, secreted Cl Inh; lanes 3 and 4, 
intracytoplasmic and secreted C] Inh from cells 
cultivated in the presence of monensin. 
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of Ci Inh glycosylation. In this case an underglyco- 
sylated form of A4, - 80000 was secreted (fig.3, 
lane 4) emphasizing that complete glycosylation of 
Cl Inh is not a prerequisite for its secretion. 
4. DISCUSSION 
Our results indicate that Clq is secreted by 
monocytes in a form identical to plasmatic Clq. 
Besides, we found that secreted Clq is hemolytical- 
ly active. There is no evidence for intracytoplasmic 
or secreted proClq. Identical results were found by 
Tenner et al. [8]. In contrast Loos [9] had evidence 
for intracellular proClq in mouse peritoneal 
macrophages. As regards fibroblastic Clq, Reid 
and Solomon [6] have shown that it may also be 
synthesized and secreted in a form of a higher 
molecular mass than purified plasmatic Clq. But 
the results of Skok et al. [lo] suggest hat a cell 
type other than fibroblasts is responsible for the 
synthesis of serum Clq and that there are distinct 
genes for the fibroblast Clq and serum Clq. 
Miiller et al. [ 1 l] suggested that Cls secreted by 
human or guinea pig peritoneal macrophages 
should be activated to explain the rapid decrease of 
C4 hemolytic activity in the cultures. As regards 
monocytic Cls we have shown that it is secreted in 
a proenzymic form. This observation could reflect 
that Cls is secreted in association with Clr as 
isolated Clr2-Cls2 has been shown to be stable [ 11. 
Besides, this non-activation of Cls does not fit with 
accepted concepts on Cl activation as association 
of Clr2-Cls2 with Clq inside Cl complex allows the 
cleavage of Cls by autoactivated Clr [2]. Our 
results indicate that monocytes are able to secrete 
Ci Inh nearly identical to its purified plasmatic 
counterpart. Similar results have been found by 
Yeung Laiwah et al. [12]. Cl, if assembled, could 
thus be protected from activation by locally pro- 
duced Ci Inh. 
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